April 28, 2009
1:09-cv-00307
News Coverage, Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
The patents for Pfizer Inc.'s blockbuster nerve pain drug Lyrica are valid, meaning Teva Pharmaceuticals Industries Ltd., Mylan Pharmaceuticals Inc. and others can't sell their planned generic versions, a Delaware federal judge said Thursday.